Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

A user experienced hair shedding despite using natural remedies but saw improvement with topical finasteride and oral minoxidil. After stopping supplements like saw palmetto and pumpkin seed oil, shedding resumed, but combining them again with finasteride and minoxidil reduced shedding.

Minoxidil use led to unwanted hair growth, but stopping the treatment was not an option due to positive effects on hairline growth. Reducing the dose and using salicylic acid were considered to manage side effects.

Astaxanthin (ASX) is highlighted as a promising supplement for treating hair loss due to its antioxidant properties. It may help with inflammation and oxidative stress, which are linked to hair loss and aging.

The conversation is about managing hair loss while on testosterone replacement therapy (TRT). Suggestions include using finasteride or dutasteride to address high DHT levels, with considerations on the impact of TRT on hair loss.

The user has been using 1mg finasteride and 2.5mg minoxidil for three months, planning to continue for a year before considering a hair transplant. Users discuss reasons for starting treatment late, potential side effects, and suggest additional treatments like dutasteride and microneedling.

The conversation discusses challenges and tips for applying liquid topical minoxidil twice a day, with users sharing their experiences and methods for managing greasy hair. Many users apply minoxidil once at night, and some combine it with finasteride for better results.

The user is concerned about post-hair transplant care, specifically regarding the use of a bandana, minoxidil, and tretinoin. They are advised to consider finasteride and possibly adjust the minoxidil dosage.

Hair thickness below 50% may not recover fully, but treatments like finasteride and minoxidil can help. Shedding involves a resting phase before new hair grows, taking about three months.

The user has been using finasteride, minoxidil, ketoconazole shampoo, and a dermaroller for hair loss, noticing slowed hair loss but no regrowth. They recently added vitamins, zinc, and rosemary oil, seeking further advice on effective treatments.

Hair loss is linked to the loss of stem cells in hair follicles, and potential treatments include gene editing and microneedling. Discussions also mention using Minoxidil, finasteride, and dermarolling to improve hair growth.

Finasteride and minoxidil are recommended for hair loss treatment, with skepticism about new treatments like Breezula. Users discuss the lack of new options and emphasize starting current treatments rather than waiting for future solutions.

The user experienced significant hair density improvement and darker hair color after four months of taking 1mg finasteride daily, but also noticed temple recession. They started using oral castor oil and microneedling, hoping to prevent further temple recession.

The user experienced significant hair shedding after using topical minoxidil for six months and finasteride for 2.5 months, and is considering switching to oral minoxidil. Other users suggest the shedding is normal and part of the treatment process, advising patience and continuation of the medication.

The user has been using finasteride for 6 months and minoxidil for 12 months to address hair loss and recently started estradiol monotherapy for additional benefits. They are unsure if their hair is regrowing and are seeking advice on their progress.

Finasteride is likely causing beard thinning due to its anti-androgen effects, which reduce DHT levels necessary for thick facial hair. Some users suggest using minoxidil to potentially counteract this effect, while others note that stopping finasteride may allow the beard to regrow.

Oral minoxidil and oral dutasteride are considered effective for hairline and hair recovery, but results vary. Topical minoxidil can still be used for beard and eyebrows even when taking oral versions.

Dairy may contain DHT precursors that could affect hair loss and prostate health, with some users noting reduced hair shedding after eliminating dairy. Individual responses to dairy and DHT blockers vary, with some attributing hair health to diet changes and others seeing no impact.

PP405 is a promising experimental topical treatment for alopecia that reactivates dormant hair follicles by targeting cellular energy, with large-scale trials planned for 2026. While it shows potential, it cannot regenerate permanently destroyed follicles, making hair transplants the only guaranteed solution for advanced baldness currently.

Baldness is difficult to cure because current treatments like finasteride, dutasteride, and minoxidil only prevent hair shedding, and new developments are mostly ineffective. Botox shows potential in aiding skin regeneration and hair growth, but maintenance therapy with treatments like dutasteride and minoxidil may still be necessary.

RU58841 lacks FDA approval due to financial and safety concerns, including potential cardiological side effects. The company abandoned further research, and users report adverse effects like heart palpitations and gynecomastia.

The user reported hair recovery on the scalp after 4 months using finasteride and 5% topical minoxidil, with anxiety as a side effect. Reducing caffeine intake helped manage anxiety, which may be linked to minoxidil's effects.

Finasteride reduced dandruff and scalp oiliness by lowering DHT, which decreases sebum production. Users also noted improvements with Nizoral and dutasteride.

PP405 is considered as a potential hair regrowth treatment, but users are skeptical due to past product failures. They compare it to Minoxidil and Finasteride, questioning its effectiveness and the intentions of pharmaceutical companies.

Hair loss is linked to scalp fibrosis and tension, which result from chronic mechanical stress and androgenic signaling. Treatments include blocking androgens with finasteride, promoting hair growth with topical minoxidil, and improving scalp mobility through exercises.

A pharmacy student proposed a hair loss treatment using minoxidil, finasteride, clascoterone, and tretinoin, aiming for high effectiveness with minimal side effects. Reactions were mixed, with some questioning its feasibility and others showing interest.

PP405 is a promising hair loss treatment that may outperform minoxidil and finasteride by reviving dormant follicles and promoting significant regrowth. Results from ongoing trials are awaited, with a potential market release between 2028-2030.

The conversation discusses the safety study of PP405, emphasizing that early trials focus on safety rather than efficacy, and that any efficacy data from such a short study should be viewed skeptically. It also highlights that the information released is primarily for securing funding, and that meaningful efficacy results are expected in later phases.

The user is considering starting oral minoxidil for hair regrowth, debating between 2.5mg and 5mg doses, while already using topical minoxidil, dutasteride, and ketoconazole shampoo. Users suggest starting with a lower dose to monitor side effects, with some recommending trying finasteride first.

A 22-year-old male is concerned about hair loss and questions the effectiveness of prescribed "Merz special" and "Revalid" products, which lack finasteride or minoxidil. Users suggest seeking a different doctor for finasteride and minoxidil treatments.

Minoxidil is highly toxic to cats and can cause fatal heart issues. Users recommend switching to oral minoxidil to protect pets.